Radio Advisory

Health systems across the country started calling Advisory Board with the same question: Why are our volumes down? In this episode, Abby Burns, Clare Wirth, and Vidal Seegobin walk through what happened after our research team dug into the data to find out whether those concerns were isolated incidents or part of a broader national trend. What they found raises a much bigger question than whether volumes are down today: What if they're not coming back the way we've assumed they would? Together, they debate the forces reshaping demand, from affordability pressures and coverage losses to site-of-care shifts and changing patient behavior. They also explore what the findings mean for health system growth strategies and why organizations may need to shift their focus from capturing volume to competing on access. We’re here to help: Podcast | 303: The hard truths behind the fight for commercial volumes Playlist | Provider Strategy and Financial Outlook Expert insight | What’s really behind the drop in hospital volumes? Report | Which services are most at risk of leaving the hospital? Research | Market trends and growth strategy Tools | Get in touch with a representative to learn more about Advisory Board's Market Intelligence tool Sponsor link: Webinar | Building financial sustainability in specialty pharmacy A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

For years, the story of ambulatory surgery centers was all about moving care out of the hospital. But the most important ASC trend today isn't growth. It's variation. Organizations are using ambulatory surgery centers to pursue very different goals. Some view ASCs as a way to relieve inpatient capacity. Others are trying to lower costs, protect market share, recruit physicians, expand access, or create room for more complex hospital care. And those strategies can vary dramatically depending on the service line, ownership model, market dynamics, and state policy environment. In this episode, host Rae Woods talks with Advisory Board researchers Nick Hula, Gaby Marmolejos, and Rachael Peroutky about why no two ASC strategies look exactly alike, and how healthcare leaders can determine the right role for ASCs in their market. We’re here to help: Webinar | How to design an ASC-specific commercial strategy Report | Site-of-care shifts 2026: Inside the latest trends and data Report | Which services are most at risk of leaving the hospital? Quick Guide | Guide to today's top orthopedic trends Report | Supplier playbook for developing an ASC commercial strategy Episode | 291: If you build it, will they buy it? The new rules for proving value in life sciences Sponsor link: Webinar | Value-based care demystified Sponsor link: Report | 4 ways health systems are pursuing lab growth A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Protecting provider margins has never been easy. But today’s combination of policy shifts, reimbursement changes, labor pressures, and evolving care models is forcing health systems to rethink where margin comes from and how to sustain it. In this episode, Abby Burns sits down with Optum Advisory’s Samantha Wyld and Jess Garber to explore how both sweeping policy changes and smaller regulatory updates are reshaping margin management. Through real-world examples, they unpack three areas of opportunity: pricing strategy, clinical documentation and coding, and capturing economies of scale many organizations have yet to realize. Together, they explain why yesterday’s margin playbook is no longer enough and what it takes to take a more strategic approach to financial performance. We’re here to help: Expert Insight | 5 assumptions executives make about revenue cycle (and what to do instead)a> Expert Insight | 6 strategies to improve your operating margins and financial resiliencea> Ready-to-Use Resource | Mapping AI’s real role in the revenue cyclea> E-book | 5 Provider Strategies to Help Improve Your Margins | Optuma> Podcast | 303: The hard truths behind the fight for commercial volumesa> Podcast | [Encore] How data savvy strategic planners will define the next era of health system growth Get in Touch | Optum Advisory: Healthcare Consulting Services Sponsor link: Quick Guide | Rethinking iodine contrast use: A stewardship maturity model A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

(This episode originally aired on February 10, 2026. Dr. Omar Lateef has since announced his intention to retire from Rush Health in June 2027.) As financial pressure mounts and the healthcare safety net continues to strain, academic medical centers are drawing on their culture of innovation to pursue better outcomes — and narrow life expectancy gaps in the communities they serve. In this episode of Radio Advisory, host Rae Woods sits down with leaders from Rush University Medical Center to explore how health systems can stay focused on results amid tightening margins, political scrutiny, and ongoing uncertainty in grant funding. Dr. Omar Lateef, President and CEO of Rush, and Dr. David Ansell, Senior Vice President for Community Health Equity, describe how Rush treats gap-reduction as a long-term operating strategy rather than a moral or messaging exercise. They share practical examples of how local partnerships, targeted investments, and day-to-day operational choices can improve outcomes while still making financial sense — and why avoiding battles over language helps keep the focus squarely on results. We’re here to help: How Rush University Medical Center is addressing the root causes of social determinants of health 264: Research funding is being slashed. What’s the real industry impact? How research funding cuts are impacting healthcare (and how to respond) 12 things CEOs need to know in 2026 Tool: How policy changes will impact your bottom line Who gets the chance to be healthy? | Rush The Rush Center for Community Well-Being at Sankofa Wellness Village | Rush Health disparities in Chicago and the work to solve them with Rush University Medical Center (AMA) The Anchor Strategy — A Place-Based Business Approach for Health Equity | New England Journal of Medicine Rush Signs on as First Partner for Local Laundry Service | Rush David Ansell Books – New: The Death Gap Sponsor link: Preserving iodine, protecting imaging

(This episode originally aired on February 3, 2026. Stay tuned towards the end of the conversation for an update on the state of pediatric hospitals midway through 2026.) Pediatric hospitals are one of the most important segments in the industry to watch right now. Although children’s hospitals make up only 5% of total hospital market share, more than 40% of U.S. children rely on Medicaid, leaving pediatric organizations disproportionately exposed as the Medicaid-related provisions of the One Big Beautiful Bill Act take effect. The pressures inside pediatric care were mounting even before this moment. After years of outperforming adult hospitals, children’s hospitals have seen margins fall from double digits to just 1% last year. Rising bad debt, higher supply and labor costs, a rapid shift toward lower margin outpatient care, and emerging challenges like declining birth rates and vaccine policy upheaval have created a perfect financial storm. While some of these dynamics are unique to pediatrics, the sector also offers an early warning signal for the rest of healthcare — and an opportunity to translate lessons across both worlds. In this episode, host Abby Burns and Advisory Board expert Vidal Seegobin break down why pediatric leaders must simultaneously manage immediate-term margin pressure, prepare for a more ambulatory-dominant model, and futureproof their organizations amid shifting demographics. Vidal also shares actionable steps leaders can take now, along with the critical lessons pediatric hospitals offer the wider healthcare ecosystem. We’re here to help: 5 insights on the state of pediatric hospitals today 12 things CEOs need to know in 2026 The State of the Healthcare Industry in 2026 Read Advisory Board's 2026 research agenda 3 trends shaping healthcare in 2026 (and how to respond) 278: Dr. Emily Oster on fighting misinformation and rebuilding trust in healthcare 277: Patient distrust is costing you. Here’s how to rebuild it. Learn how outpatient shifts can impact your organization by using Advisory Board’s Market Scenario Planner tool. Sponsor link: Q&A: How e-prescribing for vaccines may help close patient care gaps

(This episode originally aired on March 17, 2026.) As health systems pursue growth beyond traditional avenues, the role of the strategic planner is becoming increasingly complex. High level directional data is no longer enough — achieving meaningful, differentiated growth now requires leveraging granular, sophisticated data to inform investment decisions. In this episode, host Rachel Woods sits down with Advisory Board experts Sebastian Beckman and Ellie Wiles to explore how health systems can rethink strategic planning for 2026 and beyond. Together, they unpack what it should actually look like to democratize data, why data governance matters just as much as data access, and how service line leaders can partner with planners to make faster, more precise, margin savvy decisions. We’re here to help: Tools | Get in touch with a representative to learn more about Advisory Board's Market Intelligence tool Podcast | 289: What are health systems doing in 2026? Results from our survey are in. Playlist | Radio Advisory Provider Strategy and Financial Outlook Playlist Case Study | How UT Southwestern closed genomic testing gaps in prostate cancer care Sponsor link: How UCHealth lowered population-level obesity rates in their region

For years, regional health plans benefited from powerful tailwinds: Medicare Advantage growth, Medicaid expansion, and a prospering ACA marketplace. But many of those growth engines have stalled, just as new pressures emerged: rising utilization, runaway spend, pricing uncertainty and more scrutiny from patients and policy makers. The result is a dramatically different financial reality for health plans. In 2024, only eight of 33 Blues plans reported positive operating margins. In this episode, host Rae Woods sits down with Jared Landis, Vice President of Advisory Board's Health Plan Research practice, to unpack how regional plans got here and the three-year turnaround strategy regional and Blues plans are now pursuing. Together, they explore the market forces that upended the payer playbook, the operational and pricing changes plans are making to stabilize performance, and how AI-enabled transformation could reshape the future of the insurance business. Stay tuned to the end of the episode for an update on the Rural Health Transformation Program, including a key deadline this fall. We’re here to help: Episode | Ep. 257: Paul Markovich on new builds, breakups, and bold healthcare bets Episode | 305: “The work isn’t easy, but it’s clear”: How healthcare leaders are responding to the market Episode | 302: CMS announced the 2027 MA final rate. What do payers and providers need to know? Playlist | Radio Advisory Provider Strategy and Financial Outlook playlist Expert Insight | Can health plans turn their MA business around this year? Research | Health plan strategy Report | Rural health transformation funds: Where they're really going Ready-to-Use Slides | Health Plan Market Explorer Webinar | Understanding health plan decision-makers Sponsor link: Precision in motion: How digital tools support diabetes care providers A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

In this episode, Abby Burns welcomes back Megan Zweig, CEO of Rock Health Advisory, to answer audience questions submitted during Advisory Board's Research Summit in Carlsbad, California. Together, they explore how health systems are engaging with the explosion in consumer-generated data, the role of medtech and pharma in AI-enabled innovation, and why AI enablement may be able to unlock personalized care for a wider range of patients. We’re here to help: Episode | 304: Boom, bust, or bubble? Rock Health weighs in on digital health funding in 2026 Playlist | Radio Advisory Tech and AI playlist Playlist | Radio Advisory Provider Strategy and Financial Outlook playlist Research | AI in healthcare: Evaluating promising use cases Research | Truly personalized care is possible. Here's how to make it a reality. Rock Health H1 2026 funding and market overview: Durable roots, shifting routes | Rock Health Want to see a live recording of Radio Advisory? Register for an Advisory Board summit and get the insights your organization needs to navigate uncertainty and build lasting resilience. Advisory Board members: Action requested! Help shape Advisory Board’s next research agenda by taking our quick survey — share your priorities and challenges to ensure our research reflects what matters most to healthcare leaders like you. Nearly 70% of adults ages 65 and over skipped the latest COVID vaccine. Learn how health systems can treat vaccine uncertainty as a routine care gap — not patient resistance — by reading Advisory Board’s expert insight . A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Oncology is simultaneously one of healthcare's greatest success stories and one of its biggest financial challenges. Cancer care continues to benefit from breakthroughs in precision medicine and early detection, even as oncology spending is projected to approach $200 billion by 2029. At the same time, cancer programs are facing rising patient volumes, growing demand for advanced therapies, and mounting pressure to improve access and affordability. In this episode, hosts Abby Burns and Chloe Bakst welcome oncology expert Gaby Marmolejos to break down the trends shaping cancer care in 2026 and beyond. Together, they explore improvements in community-based access to advanced therapies, the promise of multi-cancer early detection testing, and the reimbursement challenges threatening program sustainability. We’re here to help: Playbook | Cell and gene therapy programs: How to launch, optimize, and deliver CGTs sustainably Roundtable referenced | Advisory Board Oncology Roundtable: Trends and tech you can’t ignore Webinar | The top 4 trends in oncology today Report | Prioritizing equity in cancer treatment: Emerging ideas Episode | 270: Service line snapshot: What every health leader needs to know Episode | Ep. 209: Predicting what oncology will look like in 2030 Help shape Advisory Board’s next research agenda by taking our quick survey — share your priorities and challenges to ensure our research reflects what matters most to healthcare leaders like you. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Value-based care is entering its accountability era. Participation in value-based arrangements continues to grow, even as financial pressures weigh down on both providers and payers. But CMMI is setting a clear tone about what it expects from stakeholders moving forward: results. Host Abby Burns sits down with Advisory Board experts Clare Wirth, Payton Grimes, and Rhea Jain to explore what’s changed — and what hasn’t — in value-based care. From Medicare Advantage turbulence to the push for specialist engagement and greater downside risk, the group breaks down what leaders need to know about how the value-based care landscape is evolving. We’re here to help: Expert Insight | VBC in 2026: What was, what’s now, and what’s next Ready-to-Use Resource | Your guide to CMMI’s 25+ innovation models Case Study | Astera and Vantris are disrupting oncology with condition-based bundles Case Study | HOPCo’s total cost of care approach to VBC in MSK care Case Study referenced | How Optum Health defines and upholds value in specialty care Episode | Ep. 243: What’s now and what’s next in value-based care Playlist | Value-Based Care Roundtable | HOME - Advisory Board VBC Roundtable: How to deliver the next era of VBC Help shape Advisory Board’s next research agenda by taking our quick survey — share your priorities and challenges to ensure our research reflects what matters most to healthcare leaders like you. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

After years of uncertainty, many healthcare executives say they’ve experienced more change in the past five years than in their entire careers. Policy shifts, evolving patient expectations, and rapid advances in AI are all colliding at once — forcing leaders to rethink how they operate and where they invest. But here’s the surprising part: the overwhelming sentiment isn’t panic. It’s clarity. In this episode, host Rachel (Rae) Woods sits down with Advisory Board researchers Morghen Philippi and Marisa Nives to share what they’re hearing from months of research conversations with leaders across the ecosystem. Together, they offer a grounded look at how peers, partners, and competitors are thinking right now — where leaders are aligned, where they’re making different bets, and what they’re prioritizing next. We’re here to help: Episode | Ep. 303: The hard truths behind the fight for commercial volumes Episode | Ep. 232: The rise of ICHRAs: Why some employers are turning to the individual market Playlist | Strategy and Financial Outlook playlist Report | 12 things CEOs need to know in 2026 Report | Survey insights: The 5 trends redefining health system strategy in 2026 Tool | Check out Advisory Board’s Market Scenario Planner and other Advisory Board analytics and data tools to inform your strategy for growth, cost control and more. Ready-to-Use Slides | Market outlook for individual and small group health insurance Webinar | How to embrace a proactive (not reactive) approach to change Q&A with a clinical pharmacist: Reimagining diabetes care A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Digital health funding is heating up—but where are the dollars going? And what does it mean for health systems’ digital health strategies? In this live episode, recorded at Advisory Board’s Research Summit, host Abby Burns sits down with Megan Zweig, President and CEO of Rock Health Advisory, for an update on what’s going on in the world of digital health funding. Together, they unpack what investment activity looks like and explore questions around what constitutes an investable thesis in 2026, how health systems are—or could be—engaging in the startup ecosystem, and what it takes to be a good incubation partner. We’re here to help: Episode | 298: Battle of the bots? Separating AI hype from value in revenue cycle Episode | 254: Stop searching for the “perfect” AI product and do this instead Playlist | Radio Advisory Tech and AI playlist Playlist | Radio Advisory Provider Strategy and Financial Outlook playlist Research | AI in healthcare: Evaluating promising use cases Rock Health Want to see a live recording of Radio Advisory? Register for an Advisory Board summit and get the insights your organization needs to navigate uncertainty and build lasting resilience. The role of pharmacists in cardiometabolic care A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

As health systems anticipate greater downward pressures on margins in the months and years to come, they’re homing their growth strategies accordingly. As we’ve been saying in our research the past couple of years, “sustainability” is now the name of the game. Here’s the conundrum: our research also shows that 90% of systems are betting on the same growth plays as their competition. And more and more, those bets converge on a common goal: win more commercial volumes. In this episode, host Abby Burns sits down with Advisory Board experts Shay Pratt and Emily Heuser to unpack the three main avenues health systems are exploring to win commercial volumes: ambulatory care, service lines, and direct-to-employer contracting. For each, they explore a “hard truth” and corresponding mindset shift leaders must face as they weigh what it will take to generate margin-accretive growth. We’re here to help: Ambulatory research | Ambulatory care Market trends research | Market trends and growth strategy Service line research | Service lines and specialty care Episode | 290: How data savvy strategic planners will define the next era of health system growth Playlist | Provider Strategy and Financial Outlook playlist Tool | Check out Advisory Board’s Market Scenario Planner and other Advisory Board analytics and data tools to inform your strategy for growth, cost control and more. Learn more about Advisory Board’s 2026 summit series. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

CMS continues to pull on the levers it has at its disposal to rein in national healthcare spend, including rulemaking around Medicare Advantage. In April, CMS announced the final rate for MA plans for CY2027, after a controversial proposed rule generated animated pushback — and a fair bit of panic — among payers. In this episode, host Abby Burns speaks with Alex Balmes, Vice President of Actuarial Services at Optum, to unpack what did — and didn’t — end up in the final rate announcement, and what that signals for the future of the Medicare Advantage program. Together, they explore the components of the final rate that are most important for payers and providers to pay attention to, respectively, and why. Also in the 2027 final announcement, but not discussed in this episode: four measures are being added or updated in Star ratings calculations (Colorectal Cancer Screening; Care for Older Adults – Functional Status Assessment; Concurrent Use of Opioids and Benzodiazepines (COB); Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults (Poly-ACH)) and three are being removed (Care for Older Adults – Pain Assessment, Medication Reconciliation Post-Discharge, Medication Therapy Management (MTM) Program Completion Rate for Comprehensive Medication Review (CMR)) We’re here to help: Read the 2027 CMS Announcement | 2027 | CMS Episode | 286: A Medicare Advantage reset — and what comes next Ready-to-Use Slides | Medicare Advantage market outlook Stay informed | Healthcare policy updates Tool | Policy Scenario Impact Calculator Connect with an Optum Advisory expert | Optum Learn more about Advisory Board’s 2026 summit series. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Maternity care touches nearly every corner of the U.S. health system. About 25% of all hospitalizations involve a mother or newborn, and maternity spending accounts for roughly 0.8% of U.S. GDP — making it one of the most economically significant service lines in health care. Against that backdrop, a little noticed decision to unbundle maternity billing codes represents a generational shift in how pregnancy, delivery, and postpartum care are paid for. In this episode of Radio Advisory, host Rae Woods sits down with Neel Shah, MD, Chief Medical Officer at Maven Clinic, to break down what the new maternity billing codes mean for providers, health plans, and patients. Together, they explore why the old bundle broke down, how unbundling could reshape care delivery, and what health leaders should be doing now as 2027 approaches. We’re here to help: Read Neel’s article | The great unbundling - by Neel Shah, MD - The Preprint Episode | Ep. 261: Maven Clinic on how holistic women's health is the key to reducing cost and engaging employees Quick guide | Guide to today's top women's healthcare trends Learn more about Advisory Board’s 2026 summit series. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Health care leaders are navigating one of the most volatile policy environments in decades. The next major reform fight hasn’t arrived yet — but in its place, a steady wave of rulemaking, regulatory shifts, and enforcement actions is driving real change. Policies are evolving faster, reversing more often, and creating a level of uncertainty that makes even the most seasoned strategists question what to act on, what to wait out, and what to ignore. This moment of policy whiplash isn’t theoretical — it’s reshaping care delivery models, workforce strategy, and long term investment decisions across the industry. In this live episode, recorded at Advisory Board’s Washington, D.C. Summit on May 4, 2026, host Rae Woods sits down with Julie Rovner — chief Washington correspondent at KFF Health News and host of the What the Health? podcast — to make sense of this “in between” moment of health policy. Drawing on four decades of reporting across multiple administrations and reform cycles, Julie helps leaders separate meaningful signals from noise, understand where real policy power sits today, and anticipate what could define the next era of health reform. We’re here to help: Playlist | Radio Advisory Health Policy playlist Expert Insight | How policy changes will impact your bottom line Tool | Policy Scenario Impact Calculator Want to see a live recording of Radio Advisory? Register for an Advisory Board summit and get the insights your organization needs to navigate uncertainty and build lasting resilience. What the Health? From KFF Health News Archives - KFF Health News 4 ways health systems are reducing EVS costs while improving performance A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

After a decidedly difficult few years in the world of nursing, things have seemingly gotten better — at least, on paper. And that’s reflective of a lot of hard work on the part of nursing leaders. But when we look at how long nurses plan to stay in the profession, we see a different story taking shape. In this episode of Radio Advisory, host Abby Burns is joined by Advisory Board nursing expert Ali Knight and Optum expert Sherilynn Quist. Together, they unpack what today’s workforce data is really telling us and what it misses, the root causes driving nurses’ discontent, and why strengthening the nursing workforce can’t be left to nurse leaders alone. We’re here to help: Episode | 274: The nurse engagement tactic leaders may be missing Expert Insight | Labor costs continue to go up. What does it mean for health systems? Expert Insight | Engage frontline staff to increase margin Webinar | 5 key trends shaping the nursing workforce today Webinar | Inform your workforce decisions with Advisory Board's benchmarks Learn more | Optum Advisory: Sustainable Growth and Margin Consulting 5 strategies to close gaps in bladder cancer care A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Across the industry, leaders are talking about a “battle of the bots”—with payers and providers racing to deploy AI across the revenue cycle. But that narrative may be more hype than reality. In this episode, Rae Woods is joined by Advisory Board experts Isis Monteiro and Elysia Culver to separate fact from fiction. They break down where AI is actually delivering value today—and why it’s showing up as efficiency gains and cost avoidance, not revenue growth. And they make the case for a different approach: stop chasing AI for its own sake, and start focusing on margin protection, operational discipline, and the problems that actually need solving. We’re here to help: Report | Revenue cycle claims denial benchmarks Report | Addressing plan-provider friction: 3 insights from Optum’s Payer-Provider Abrasion survey Case Study | 3 steps to prevent prior authorization denials Learn | AI in healthcare: Evaluating promising use cases Playlist | Radio Advisory Provider Strategy and Financial Outlook playlist Playlist | Radio Advisory Tech and AI playlist Learn about Advisory Board's 2026 summits A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

After more than a decade of effort, healthcare still struggles with the same consumer pain points: affordability, access, and trust. Despite investments in price transparency, virtual care, and navigation tools, the patient experience remains fragmented, leaving leaders to wonder whether healthcare consumerism ever truly delivered on its promise. In this episode, host Rae Woods invites Advisory Board experts Devin Airey, Shay Pratt, and Natalie Trebes to take a candid look at why the consumer revolution stalled, what consumerism tactics healthcare leaders need to let go of, and where the industry should double down heading into the next decade. We’re here to help: Report | 6 insights on consumer preferences in healthcare Report | Setting up your ambulatory network for the future Expert Insight | 3 strategies to boost healthcare consumer engagement Expert Insight | 3 trends shaping healthcare in 2026 (and how to respond) Playlist | Radio Advisory Provider Strategy and Financial Outlook playlist Subscribe to The Daily Briefing, a must-read daily newsletter for thousands of healthcare executives across the nation A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

What has price transparency data taught us about healthcare prices? Price transparency laws were originally put in place to make it possible for patients to act like consumers. We’re not there yet. But as federal requirements and enforcement tighten, health plans and providers are sharing more and better data, giving us a clearer picture of the price of care across services, organizations, and markets. In this episode, host Abby Burns sits down with CEO of Revelar Analytics, Maria Nikol, to better understand how and why leaders across the industry should leverage price transparency data to help them navigate mounting financial pressures. Maria shares concrete examples of how organizations are using the data to defend rates, uncover underpayment, and prepare for rate negotiations — while also breaking down common data pitfalls and why interpretation matters. They also discuss recent and proposed policy changes and what they mean for healthcare leaders in 2026 and beyond. We’re here to help: Infographic | Real-time transparency Report | 4 steps for successful risk contracting with payers Expert Insight | 3 ways to make VBC contracting easier Learn more | Revelar Analytics l Price Transparency l Home Page 2026 State of Healthcare Procurement: Cost, Quality, Resilience A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.